[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 19, Issue 2 (4-2021) ::
Int J Radiat Res 2021, 19(2): 357-363 Back to browse issues page
18-F-Fluoroglucosylation of an arginine-arginine-leucine peptide as a potential tumor imaging agent for positron emission tomography
R.F. Wang, Z.G. Wang, M.M. Yu , Y.H. Chen, B. Shi, W. Xue
Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China , mingmingyu@vip.sina.com
Abstract:   (2951 Views)
Background: Based on the principle of oxime formation, 18F labeling of polypeptides can be achieved via a reaction between an aldehyde group-containing 18F-prosthetic group and an aminooxy-modified polypeptide. The focus of this study was to investigate the one-step synthesis of 2-[18F] fluoro-2-deoxyglucose (18F-FDG)- arginine-arginine-leucine (RRL) from open-ring 18F-FDG and the aminooxy-modified RRL peptide cyclo(RRLfK)-ONH2 and to study the biological distribution of 18F-FDG-RRL in a nude mouse model of human neuroglioma. Materials and Methods: The aminooxy-modified RRL peptide cyclo(RRLfK)-ONH2 was used as the precursor to react with 18F-FDG at 100 ℃ and different pH values for 30 minutes to synthesize 18F-FDG-RRL. The labeling yield, radiochemical purity, and in-vitro stability of the product were measured, and the biological distribution of 18F-FDG-RRL in tumor-bearing nude mice was analyzed at 30 minutes, 60 minutes and 120 minutes. Results: The labeling yield of 18F-FDG-RRL was (25.5±5.0) % at a pH of 2.0, and its radiochemical purity was greater than 95%. 18F-FDG-RRL was mainly excreted through the kidneys, with rapid blood clearance. One hour after injection, the uptake of 18F-FDG-RRL in tumors was (1.83±0.12) injected dose per gram of tissue (%ID/g), with a tumor/muscle ratio of 7.03±0.04, a tumor/blood ratio of 4.36±0.21 and a tumor/brain ratio of 7.53±1.37. Conclusion: The synthesis of 18F-FDG-RRL can be achieved through oximation. This method is straightforward and easy to promote. 18F-FDG-RRL has rapid blood clearance and high uptake by tumors.
Keywords: Oxime, 2-fluoro-2-deoxyglucose, arginine-arginine-leucine, peptide.
Full-Text [PDF 1937 kb]   (339 Downloads)    
Type of Study: Original Research | Subject: Medical Physics
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Wang R, Wang Z, Yu M, Chen Y, Shi B, Xue W. 18-F-Fluoroglucosylation of an arginine-arginine-leucine peptide as a potential tumor imaging agent for positron emission tomography. Int J Radiat Res. 2021; 19 (2) :357-363
URL: http://ijrr.com/article-1-3659-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 2 (4-2021) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.04 seconds with 32 queries by YEKTAWEB 4410